Heron Therapeutics Inc (HRTX)

Operating Cash Flow Growth

79.64%

Quarterly · Period ending:

HRTX logo

HRTX Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported79.64%
HRTX Quarterly Cash from Operations YoY % (-100.00% → 79.64%)
High-resolution chart · PNG

HRTX operating cash flow growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Heron Therapeutics Inc Operating Cash Flow Growth — Quarterly
Period endingOperating Cash Flow Growth
79.6375%
82.6381%
22.0374%
-60.5162%
-136.0556%
6.7886%
-579.8371%
136.7251%
83.0517%
61.7831%
106.5407%
75.2361%
4.2576%
43.3305%
17.0666%
30.2825%
54.9578%
-4.7713%
13.8829%
-26.4232%
-9.9778%
-27.3357%
-94.8104%
-65.1054%
-147.8665%
32.8186%
19.4404%
29.0027%
61.949%
20.5613%
28.9762%
11.5047%
-89.6004%
-22.0083%
-22.3982%
-12.2525%
-18.1483%
-56.3507%
-66.3974%
-81.5919%
-71.3762%
-64.4771%
-80.0576%
-3.3895%
-26.7954%
-25.1766%
-33.5515%
-55.7067%
-15.2943%
-97.3747%
-57.1755%
-340.2708%
-172.5006%
-93.8398%
-147.4747%
-5.5681%
-153.9003%
-301.0742%
-169.0217%
0%
15.1844%
-1,578.6885%
54%
-20.4896%
50.4567%
98.0137%
66.8819%
55.6047%
40.7514%
56.0344%
-38.5727%
5.1718%
-315.2016%
-13.2091%
-39.9486%
-44.8314%
66.4151%
-130.2184%
-49.4242%
-131.6261%
-115.8601%
1,238.1271%
-23.9001%
-12.6984%
25.7295%
3.807%
-4.9938%
-60.4167%
-23.8977%
-4.1318%
-33.9465%
28.3582%
-61.2276%
-35.4465%
45.5558%
36.0534%
-48.622%
9.5545%
-43.8269%
-110.8406%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.